<?xml version="1.0" encoding="UTF-8"?>
<p>The presence of interventions alone is not sufficient; the greatest prevention benefits are reported when NSP and OST are implemented at high coverage and in combination.
 <xref rid="bib6" ref-type="bibr">6</xref>, 
 <xref rid="bib7" ref-type="bibr">7</xref>, 
 <xref rid="bib8" ref-type="bibr">8</xref> WHO emphasises that in countries where injecting drug use occurs, priority should be given to immediate implementation of NSP and OST,
 <xref rid="bib9" ref-type="bibr">
  <sup>9</sup>
 </xref> and recommends that countries aim to distribute in excess of 200 needle-syringes per PWID annually, and to provide OST to more than 40 people per 100 PWID.
 <xref rid="bib5" ref-type="bibr">
  <sup>5</sup>
 </xref> In 2010, however, a comprehensive review reported very low coverage of all of the above interventions among PWID globally, noting that there were few countries where coverage was considered sufficient to prevent viral transmission.
 <xref rid="bib10" ref-type="bibr">
  <sup>10</sup>
 </xref>
</p>
